Protocol for harmonization of randomized trials testing the addition of behavioral therapy to buprenorphine for opioid use disorder.
McHugh RK, Bailey AJ, Weiss RD, Fitzmaurice GM.
Drug Alcohol Depend Rep. 2024 Jun. 11:100226. PMID: 38545409
Professor of Psychiatry
Psychiatry-McLean Hospital
Harvard Medical School
McHugh RK, Bailey AJ, Weiss RD, Fitzmaurice GM.
Drug Alcohol Depend Rep. 2024 Jun. 11:100226. PMID: 38545409
McHugh RK, Fitzmaurice GM, Votaw VR, Geyer RB, Ragnini K, Greenfield SF, Weiss RD.
J Subst Use Addict Treat. 2024 May. 160:209296. PMID: 38272120
BraƱas MJAA, Frankenburg FR, Temes CM, Fitzmaurice GM, Zanarini MC.
J Clin Psychiatry. 2023 11 08. 84(6). PMID: 37943989
Bitran AM, Temes CM, Gecha TC, Glass IV, Frankenburg FR, Fitzmaurice GM, Zanarini MC.
J Pers Disord. 2023 Nov. 37(6):678-690. PMID: 38038657
Ren B, Lipsitz SR, Weiss RD, Fitzmaurice GM.
Stat Methods Med Res. 2023 10. 32(10):1973-1993. PMID: 37647237
Zanarini MC, Hein KE, Temes CM, Frankenburg FR, Fitzmaurice GM.
J Pers Disord. 2023 08. 37(4):456-468. PMID: 37721779
Ren B, Lipsitz SR, Weiss RD, Fitzmaurice GM.
Drug Alcohol Depend. 2023 09 01. 250:110897. PMID: 37544038
Whitton AE, Kumar P, Treadway MT, Rutherford AV, Ironside ML, Foti D, Fitzmaurice G, Du F, Pizzagalli DA.
Mol Psychiatry. 2023 Dec. 28(12):5272-5281. PMID: 37402852
Ren B, Lipsitz SR, Fitzmaurice GM, Weiss RD.
Multivariate Behav Res. 2024 Jan-Feb. 59(1):110-122. PMID: 37379399
Zanarini MC, Martinho E, Temes CM, Glass IV, Aguirre BA, Goodman M, Fitzmaurice GM.
Borderline Personal Disord Emot Dysregul. 2023 Mar 09. 10(1):9. PMID: 36895048